Ana Lariu

Ana Lariu

Auto-generated profile, based on publicly available information

Ana Lariu

Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital of Basel, Spitalstrasse 21, 4031 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2025 in JPRAS Open
Verified
Journal Article
Open access
AFAdriano Fabi
Adriano Fabi
Andre Silva AlvesAndre Silva Alves
Andre Silva Alves
ANAlbert Neutzner
Albert Neutzner
SFStephan Frank
Stephan Frank
ALAna Lariu
Ana Lariu
EKElisabeth Kappos
Elisabeth Kappos
Neurolymphatic dysfunction has been linked to cognitive decline and implicated in the pathogenesis of neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Despite its growing recognition, the potential role of pharmacological or surgical neurolymphatic modulation remains poorly understood. This review summarizes current evidence on the neurolymphatic system’s anatomy, physiology and its involvement in neurodegenerative diseases. It also examines emerging pharmacological and lymphatic reconstructive techniques. A comprehensive literature search was conducted in PubMed, yielding 187 studies related to the neurolymphatic system. Studies were screened for the following topics: (1) Anatomy and physiology of the neurolymphatic system, (2) The association between neurolymphatic dysfunction and neurodegenerative diseases, (3) Pharmacological and (4) Microsurgical neurolymphatic modulation. Current evidence suggests that the neurolymphatic system facilitates drainage of interstitial and cerebrospinal fluid to the deep cervical lymph nodes. Preclinical models suggest that enhancing their clearance may promote the clearance of neurotoxic proteins and potentially improve cognitive function. Scientific evidence on neurolymphatic modulation in neurodegenerative diseases is scarce. Both pharmacological and microsurgical modulatory techniques remain experimental approaches for neurodegenerative diseases, with a significant potential to improve patients’ quality of life. However, further research is warranted to establish their safety, feasibility, and efficacy. The current knowledge gaps underscore the need for a detailed mapping of the neurolymphatic pathways, preclinical evaluation, and translational interdisciplinary trials.

10 November 2026
Verified
Book Chapter
Closed access
PDF file
Alex OrădanAlex Orădan
Alex Orădan
Alex OrădanAlex Orădan
Alex Orădan
RIRăzvan George Iaz
Răzvan George Iaz
IGIrina Grosu
Irina Grosu
ALAna Lariu
Ana Lariu

10 November 2026
Verified
Book Chapter
Closed access
RDRuben Dammers
Ruben Dammers
TPTeodora Diana Pană
Teodora Diana Pană
IGIrina Grosu
Irina Grosu
ALAna Lariu
Ana Lariu

10 November 2026
Verified
Book Chapter
Closed access
MDMaximilian Dindelegan
Maximilian Dindelegan
Alex OrădanAlex Orădan
Alex Orădan
RIRăzvan George Iaz
Răzvan George Iaz
ALAna Lariu
Ana Lariu

10 November 2026
Verified
Book Chapter
Closed access
PDF file
Alex OrădanAlex Orădan
Alex Orădan
AVAlex Victor
Alex Victor
TPTeodora Diana Pană
Teodora Diana Pană
TBThea Brad
Thea Brad
ALAna Lariu
Ana Lariu
VVVictor Volovici
Victor Volovici

10 November 2026
Verified
Book Chapter
Closed access
PDF file
Alex OrădanAlex Orădan
Alex Orădan
AVAlex Victor
Alex Victor
MDMaximilian Dindelegan
Maximilian Dindelegan
AIAlexandru Ilie-Ene
Alexandru Ilie-Ene
ISIoana-Alexandra Stoia
Ioana-Alexandra Stoia
ALAna Lariu
Ana Lariu